Education:
- PhD, Economics, McGill University
Research Interests:
- Health policy and healthy aging
- Chronic disease management
- Alzheimer’s disease and dementia prevention and management
- Disparities in utilization and effectiveness of pharmaceutical therapies
- Pharmacist regulations
- Health insurance design
Courses Taught:
Biography:
Douglas Barthold is a health economist and Associate Professor at the University of Washington, specializing in the intersection of health policies, healthcare utilization, and health outcomes, with particular focus on aging, dementia, and prescription drug policy. He is faculty at the Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, serves as Co-Director of the Program in Health Economics and Outcomes Research Methodology (PHEnOM), and is a Board Member of the Washington State Prescription Drug Affordability Board. His research explores how health insurance design and prescription drug costs impact management of chronic diseases, including mid-life risk factors for dementia. Barthold holds a Ph.D. in Economics from McGill University and previously did postdoctoral research at the Schaeffer Center for Health Policy and Economics at the University of Southern California.
Selected Publications:
https://sites.google.com/site/douglasbarthold/peer-reviewed-publications
Education:
- BSci, Pharmacy,
- MS, Pharmacology
- PhD, Pharmacology
Courses Taught:
Research Interests:
- Early discovery of Anti-seizure drugs
- Animal seizure and epilepsy models for drug discovery
- Pharmaco-resistant epilepsy
- Impact of adherence on seizure control
- comorbidities of epilepsy
- Prevention and disease modification of epilepsy
- Role of the community pharmacist in the chronic management of the patient with epilepsy
Biography:
H. Steve White, RpH, Ph.D, earned his baccalaureate degree in Pharmacy and a M.S. in Pharmacology at Idaho State University. He earned his Ph.D. in Pharmacology at the University of Utah where he rose through the academic ranks after joining the College of Pharmacy faculty in 1986.
Before joining the University of Washington School of Pharmacy as Chair of the Department of Pharmacy, White was the principal investigator and scientific director of the NIH-sponsored Anticonvulsant Drug Development (ADD) Program, established in 1975 to identify novel anticonvulsant drugs using established animal seizure and epilepsy models.
White’s research is focused on understanding the factors that contribute to the initiation, propagation, and amelioration of seizure activity.
White has been the recipient of significant research funding from the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), and he and his collaborators have published over 170 original papers pertaining to the mechanism of action and the pharmacology of antiepileptic drugs. In addition to his academic service, he served as Research Director of CURE (Citizen’s United for Research in Epilepsy), the largest non-governmental provider of epilepsy research funding, from November 2011 until October of 2015, where he assisted in the development of strategic programs that advance transformative epilepsy research that may someday lead to a cure or disease modifying therapy for the patient at risk for developing epilepsy. He continues to serve as a Research Advisor to CURE’s team-science initiatives. He has been a co-organizer of two NIH-sponsored workshops on models of refractory epilepsy and epileptogenesis and currently serves on the organizing committee of the biannual Eilat Conferences on Antiepileptic Drug Development. Additionally, White has been actively engaged as a mentor for the next generation of neuroscientists and epilepsy educators and is frequently invited to speak at national and international congresses.
In 2011, White received an Honorary Doctor of Science from The University of Copenhagen Faculty of Pharmaceutical Sciences, Copenhagen, Denmark. In 2014, he was named the 2014 recipient of the Epilepsy Foundation’s Lifetime Accelerator Award, in recognition of his commitment and pioneering contributions to the field of epilepsy and seizures.
White was appointed as the new chair for the Department of Pharmacy in January, 2016.
Selected Publications:
https://www.ncbi.nlm.nih.gov/pubmed/?term=H.+Steve+White
Education
- PhD, Public Policy (Health Economics), University of Chicago, 2004
- MS, Biostatistics, UNC-Chapel Hill, 1999
- MS, Industrial Pharmacy, University of Toledo, 1997
- BS, Pharmaceutical Technology, Jadavpur University India
Courses Taught
- Welfare Economics foundations for cost-effectiveness analysis (HSERV 583, ’11 & ‘12) – 1.5 hour sessions
- Understanding the role of uncertainty in decision models (HSERV 583, ’13 & ‘14) – 1.5 hour sessions
- Quantitative methods for valuing information in health care (HSERV 584, ‘11) – 1.5 hour sessions
- Introduction to comparative effectiveness methods (HSERV 523, ’11; HSERV 513 & HSERV 592, ’12) – 1.5 hour sessions
- Instrumental variable methods (HSERV 523, ‘11) – 1.5 hour session
- Financing healthcare (HuBio 555, ’13, ‘14) – 1.5 hour session to 250 2nd year medical students
- Quantile regression methods (HSERV 525, ’11, HSERV 523, ‘12) – 1.5 hour sessions
- Variations in healthcare spending: Observations & Implications (PHARM 568, ’14 -‘16) – 1.5 hour sessions
- Causal inference in observational studies (HSERV 525), Spring 2013 -2019- Ten 3 hour sessions.
Research Interests
- comparative and cost-effectiveness analyses
- causal inference methods
- program evaluation, and outcomes research
Biography
Anirban Basu, PhD, MS, is a health economist and a statistician who specializes in research on comparative and cost effectiveness analyses, causal inference methods, program evaluation, and outcomes research. He directs The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute at the University of Washington, Seattle, with appointments in the departments of Pharmacy, Health Services, and Economics at the university. He is a Faculty Research Fellow at the National Bureau of Economic Research, and a Fellow of the American Statistical Association. He was one of the panelists for the Second Panel on the Cost-Effectiveness Analysis in Health and Medicine. He studies heterogeneity in clinical and economic outcomes, micro behavior with respect to heterogeneous information, and the value of individualized care. He teaches topics in health economics, decision analysis, cost-effectiveness analysis, and health services research methods. He received his PhD in Public Policy (Health Economics Specialization) from The University of Chicago and an MS in Biostatistics from the University of North Carolina at Chapel Hill. http://faculty.washington.edu/basua/
Selected Publications
https://scholar.google.com/citations?user=AR72duAAAAAJ&hl=en